Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey
1 other identifier
observational
306
5 countries
8
Brief Summary
The objective of this survey is to establish the clinical course of vision loss and recovery in patients with a genetically confirmed diagnosis of Leber Hereditary Optic Neuropathy (LHON). Visual acuity changes over time from onset of symptoms and from visual acuity nadir will be the main endpoint analysed. The survey will collect historically documented visual acuity data for all patients at participating sites with a genetically confirmed diagnosis of LHON. No exclusion criteria apply. Patients are not required to attend the clinic for the survey. Data will be collected in a completely anonymous manner. Ethical approvals and data release agreements will be obtained as required by local regulations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2013
Shorter than P25 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2013
CompletedFirst Posted
Study publicly available on registry
July 8, 2013
CompletedStudy Start
First participant enrolled
August 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedMay 15, 2014
May 1, 2014
6 months
June 26, 2013
May 14, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Visual acuity
The Entire duration of the disease patient by patient basis up to the date of completion of the Case Report Form (CRF).
average 0 to 10 years (retrospective)
Study Arms (1)
Patients with LHON
Eligibility Criteria
patients with genetically confirmed diagnosis of LHON
You may qualify if:
- patients with genetically confirmed diagnosis of LHON
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
University Hospitals Leuven
Leuven, 3000, Belgium
Glostrup Hospital/National Eye Clinic of the Kennedy Center/University of Copenhagen Department of Ophthalmology
Glostrup Municipality, 2600, Denmark
CHU Bordeaux
Bordeaux, 33000, France
CIC/CMR CHNO des Quinze-Vingts
Paris, 75012, France
Universty of Bari
Bari, 70100, Italy
Fondazione G.B. Bietti
Rome, 000199, Italy
San Raffaele Hospital
Segrate, 20132, Italy
University Eye Clinic
Ljubljana, 1000, Slovenia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jose-Alain Sahel, MD
Centre de Recherche Institut de la Vision INSERMN
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2013
First Posted
July 8, 2013
Study Start
August 1, 2013
Primary Completion
February 1, 2014
Study Completion
February 1, 2014
Last Updated
May 15, 2014
Record last verified: 2014-05